Gretchen Repasky

POSITIONS AND ROLES OF SIGNIFICANCE

Senior Researcher, Research Training Coordinator, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2010–present)

Doctoral Program Coordinator, Doctoral Programs in Biomedicine and Oral Sciences, Doctoral School in Health Sciences, University of Helsinki, Finland (2014–2015)

Interim RNAi Unit Coordinator, FIMM Technology Centre, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2010–2011)

Assistant Professor, Biology and Chemistry/Physics Departments, Birmingham-Southern College, Birmingham, AL USA (2006–2009)

Assistant Professor of Biochemistry, Chemistry Department, The Colorado College, Colorado Springs, CO USA (2004–2006)

Post-doctoral Research Fellow, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC USA (2000–2004)

Adjunct Professor, Department of Biology, Meredith College, Raleigh, NC USA (2003–2004) 

Course Instructor, Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA (2001-2003) 

Course Instructor, Carolina College for Lifelong Learning, General Alumni Association, University of North Carolina at Chapel Hill, Chapel Hill, NC USA (2002)

Teaching Assistant, Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA (2001-2003)

Summer Research Intern, Drug Disposition and Metabolism Unit, Analytical Chemistry, Zeneca Pharmaceuticals, Wilmington, DE USA (1992, 1993)  

PROGRAMS MANAGED

FIMM Doctoral Training Committee, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2015-present)

FIMMPOD, FIMM Postdoctoral and Senior Researcher Professional Development Program, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2014-present)

Doctoral Programs in Biomedicine and Oral Sciences, Doctoral School in Health Sciences, University of Helsinki, Finland (2014–2015)

FIMM-EMBL International PhD Program, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2010-present)

PROJECTS 

WikiDruget, Institute for Molecular Medicine, Finland, University of Helsinki, Finland(2015-present) 

Pfizer IIR Project, Studies of axitinib and axitinib drug combinations as BCR-ABL1 T315I-selective therapies for use in drug-resistant CML and Ph+ ALL, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2014-2016)

EU-OPENSCREEN, ESFRI Project, Institute for Molecular Medicine, Finland, University of Helsinki, Finland (2011–2013)

LIBRA/Leading innovative measures to reach gender balance in research activities, Horizon 2020 (2015-2018)

Research Corporation CC6677, Cottrell College Science Award:  Biochemical Role of the PEDF Tumor Suppressor in Ras-Mediated Pancreatic Oncogenesis (2007-2009)

The Colorado College, Natural Science Faculty Research & Development Funds and Faculty-Student Collaborative Research Awards:  The Biochemical Role of the Cyclooxygenase-2 Enzyme:  Implications in the Development of Colorectal Cancer (2005-2006) and Biochemical Role of the PEDF Tumor Suppressor in Ras-Mediated Pancreatic Oncogenesis (2005)

Life Sciences Research Foundation, Merck Fellow:  The Mechanism of Activation and Role of Cyclooxygenase-2 in Ras-Mediated Transformation (2001-2004)

National Institutes of Health, Post-Doctoral NIH Training Grant, Lineberger Post-Doctoral Fellowship Award (2000-2001)

National Institutes of Health, Pre-Doctoral NIH Training Grant, Cell and Molecular Biology Training Program (1994-1995)

PUBLICATIONS

Note:  Surname change from Murphy to Repasky in 2004